P. aeruginosa Infection Differs Between Cystic Fibrosis and Non-CF Bronchiectasis, Study Shows


Triclosan, often maligned, may have a good side — treating cystic fibrosis infections


Vertex, NHS England no closer to Orkambi settlement


Proof that Mycobacterium Abscessus Doesn’t Always Lead to Transplant Failure


Azithromycin Reduced Pulmonary Exacerbation Risk in Cystic Fibrosis


Health Canada Approves Symdeko to Treat CF Patients 12 and Up with Certain Gene Mutations


Omega-3 Essential Fatty Acids May Benefit Cystic Fibrosis Patients, Mouse Study Suggests


Supplemental antioxidants may reduce exacerbations in cystic fibrosis


AzurRx BioPharma reports positive results in its Phase 2a trial of pancreatitis drug


Nanoparticles Therapy May Be ‘One-Size-Fits-All’ Approach for CF, Study Suggests

